STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS - Trademark Details
Status: 601 - Abandoned - Express
Image for trademark with serial number 77813061
Serial Number
77813061
Word Mark
STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
Status
601 - Abandoned - Express
Status Date
2010-04-12
Filing Date
2009-08-26
Mark Drawing
4000 - Standard character mark Typeset
Law Office Assigned Location Code
M20
Employee Name
HOLTZ, ALLISON A
Statements
Goods and Services
Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
Pseudo Mark
STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR END POINTS IN DIABETES MELLITUS
Classification Information
International Class
42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2009-09-03
Primary Code
042
Correspondences
Name
Tanya Fickenscher Leonard
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2009-09-01NEW APPLICATION ENTERED IN TRAM
2009-09-03NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2009-09-04NOTICE OF PSEUDO MARK MAILED
2009-11-05ASSIGNED TO EXAMINER
2009-11-05NON-FINAL ACTION WRITTEN
2009-11-06NON-FINAL ACTION MAILED
2009-12-28TEAS REVOKE/APPOINT ATTORNEY RECEIVED
2009-12-28ATTORNEY REVOKED AND/OR APPOINTED
2010-04-09TEAS EXPRESS ABANDONMENT RECEIVED
2010-04-12ABANDONMENT - EXPRESS MAILED
2010-04-12ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT